Taves, Christopher David

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Taves, Christopher David's trades of Medipharm Labs Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
32.03
Quantity 23,401 -6.4%
Value CA$2,756,615
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-09
S Sale
23,401 -6.4%
32.03
CA$2,756,615 		23,401 -6.4% 32.03 CA$2,756,615